TWI381862B - Method and method of hand - push intravenous injection of pharmacokinetic model - Google Patents

Method and method of hand - push intravenous injection of pharmacokinetic model Download PDF

Info

Publication number
TWI381862B
TWI381862B TW98133924A TW98133924A TWI381862B TW I381862 B TWI381862 B TW I381862B TW 98133924 A TW98133924 A TW 98133924A TW 98133924 A TW98133924 A TW 98133924A TW I381862 B TWI381862 B TW I381862B
Authority
TW
Taiwan
Prior art keywords
concentration
drug
site
unit
action
Prior art date
Application number
TW98133924A
Other languages
Chinese (zh)
Other versions
TW201113061A (en
Original Assignee
Changhua Christian Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Changhua Christian Hospital filed Critical Changhua Christian Hospital
Priority to TW98133924A priority Critical patent/TWI381862B/en
Publication of TW201113061A publication Critical patent/TW201113061A/en
Application granted granted Critical
Publication of TWI381862B publication Critical patent/TWI381862B/en

Links

Description

應用藥物動力學模型的手推靜脈注射藥劑計算系統及方法Hand-push intravenous drug calculation system and method using pharmacokinetic model

本發明一種應用藥物動力學模型的手推靜脈注射藥劑計算系統及方法,係運用多腔室加作用部位的藥物動力學模型計算病患作用部位之藥劑濃度,方便使用者控制投藥劑量及掌握藥劑反應時間。The invention discloses a system and a method for calculating a hand-injected intravenous medicament using a pharmacokinetic model, which uses a pharmacokinetic model of a multi-chamber plus a working site to calculate a concentration of a drug at a working site of a patient, and is convenient for the user to control the dosage and master the medicament. Reaction time.

以麻醉工作為例,引導麻醉或短期鎮靜的過程中,常需要推注靜脈麻醉藥物,雖然藥物動力學的模型已經發展完善,然而,卻沒有將之應用在手推藥物的產品,以至於仍須仰賴臨床醫師的經驗,可能有所誤差。目前尚無任何方法可利用藥物動力學模型與分析大量病患的資料所取得的模型參數,以可靠而便捷的方法來估算手推投藥之後在作用部位之藥物濃度變化。這種方法使醫師可以精確控制手推投藥劑量,使麻醉鎮靜更安全,提升醫療品質,增進手術團隊工作效率。Taking anesthesia as an example, in the process of guiding anesthesia or short-term sedation, it is often necessary to push intravenous anesthesia drugs. Although the pharmacokinetic model has been developed, it has not been applied to the products of hand-pushing drugs, so that it still remains Subject to the experience of the clinician, there may be errors. There is currently no method for using the pharmacokinetic model to analyze the model parameters obtained from a large number of patients, and to estimate the drug concentration changes at the site of action after hand-pushing in a reliable and convenient way. This method allows the physician to precisely control the dosage of the hand push, make the anesthesia calm and safe, improve the quality of the medical treatment, and improve the efficiency of the surgical team.

應用藥物動力學的模型與資訊的既有產品係將之應用於針筒幫浦之中,本系統則將之應用在重覆手推注射的情境,尤其適用引導麻醉,能快速而平穩的導入麻醉狀態。The existing product line of the application of pharmacokinetic models and information is applied to the syringe pump. The system is applied to the situation of repeated hand-push injection, especially for guiding anesthesia, which can be introduced quickly and smoothly. Anesthesia.

由於既有產品需要設置針筒幫浦、連聯結注射管線與連結電源等步驟始能啟動,若是用於引導麻醉或是緊急處置,手續過於繁複,難收時效。Since the existing products need to be equipped with a syringe pump, a connection injection line and a connection power source, the steps can be started. If it is used to guide anesthesia or emergency treatment, the procedure is too complicated and time-consuming.

由此可見,上述習用物品仍有缺失,實非一完善之設計,而亟待加以改良。It can be seen that the above-mentioned conventional items are still missing, which is not a perfect design and needs to be improved.

本案發明人鑑於上述習用麻醉方法所衍生的各項缺點,乃加以改良創新,並經過多年研究後,終於成功研發完成本件一種應用藥物動力學模型的手推靜脈注射藥劑計算系統及方法。In view of the shortcomings derived from the above-mentioned conventional anesthesia methods, the inventors of the present invention have improved and innovated, and after years of research, finally successfully developed a hand-injection intravenous drug calculation system and method for applying the pharmacokinetic model.

本發明之主要目的即在於使手推靜脈注射藥劑能簡易、快速而平穩的達到安全而有效的藥物濃度範圍。The main object of the present invention is to enable a hand-injected intravenous medicament to achieve a safe and effective range of drug concentrations in a simple, rapid and smooth manner.

本發明之次要目的即在於藉由使用者介面獲得選擇藥物與藥物動力學模型、輸入病患基本資料、劑量設定與投藥記錄等資訊,以群體藥物動力學的統計結果推算個體的作用部位藥物濃度函數。The secondary objective of the present invention is to obtain information on the selected drug and pharmacokinetic model, input basic patient data, dose setting and drug administration record through the user interface, and calculate the drug at the action site of the individual by using the statistical results of the population pharmacokinetics. Concentration function.

可達成上述發明目的之一種應用藥物動力學模型的手推靜脈注射藥劑計算系統及方法,係透過一使用者介面提供藥物與模型選擇、輸入病患基本資料(例如:性別、年齡、身高體重等)、劑量設定(配方濃度、每次投藥量)、及Ce 到達峰值警示設定、編輯投藥記錄、自動新增投藥記錄設定,將上述相關參數儲存於儲存單元中,再由處理單元將上述參數,應用藥物動力學模型計算出作用部位濃度的時間函數,Ce (t)。A hand-injection intravenous drug calculation system and method using the pharmacokinetic model for achieving the above object, which provides a drug and model selection through a user interface, and inputs basic patient data (eg, gender, age, height and weight, etc.) ), dose setting (formulation concentration, dose per dose), and Ce reach peak warning setting, edit medication record, automatically add medication record setting, store the above relevant parameters in the storage unit, and then the above parameters are processed by the processing unit. The pharmacokinetic model was used to calculate the time function of the concentration of the site of action, Ce (t).

當按下執行後將於使用者介面顯示單元中顯示目前作用部位濃度(Ce )、投藥總量、Ce 峰值、到達Ce 峰值的時間、Ce 降至底限所需時間等,並配合一計時單元及一音效與燈號警示單元,當Ce 降至底限時,藉由文字、圖形顯示與音效、燈號警示告知使用者藥劑濃度是否在使用者需求的安全且有效範圍內,通知使用者手動推注藥劑,使用者可視臨床需求而調整設定作用部位濃度底限、作用部位濃度到達峰值警示、與自動新增投藥記錄等設定,達到便捷有效的控制病患所需藥劑之目的。。另外,使用者更可依據手術進行之狀況,投藥並記錄,或修改Ce 底限等相關設定,或是修正病人基本資料,以達成安全且準確地掌握及提供適合病患的劑量之目的。When pressed, the user's interface display unit will display the current concentration of the active site ( Ce ), the total dose, the Ce peak, the time to reach the Ce peak, the time required for Ce to fall to the bottom limit, etc., and cooperate with a timing unit. And an audio effect and signal warning unit, when Ce falls to the bottom limit, the user is notified by manual text, graphic display and sound effect, and light warning to inform the user whether the drug concentration is within the safe and effective range of the user's demand. Injecting the drug, the user can adjust the setting of the concentration limit of the action site, the peak of the concentration of the action site, and the automatic new drug administration record according to the clinical demand, so as to achieve convenient and effective control of the drug required by the patient. . In addition, the user can also administer and record according to the condition of the operation, or modify the relevant settings such as the Ce floor, or correct the basic data of the patient to achieve safe and accurate grasp and provide the dosage suitable for the patient.

請同時參閱圖一、圖二及圖三所示,本發明包含:一儲存單元2,該儲存單元2提供各項設定參數的儲存。Referring to FIG. 1 , FIG. 2 and FIG. 3 simultaneously, the present invention comprises: a storage unit 2, which provides storage of various setting parameters.

一選擇藥物與模型模組10,該選擇藥物與模型模組10提供多種藥物及藥物動力學模型供使用者選擇。A drug and model module 10 is selected that provides a plurality of drug and pharmacokinetic models for selection by the user.

一病患基本資料設定模組11,提供使用者輸入病患基本參數,例如:年齡、身高、體重、性別(請參閱圖二所示)。輸入結果將儲存於儲存單元2中。A patient basic data setting module 11 provides the user with input of basic patient parameters such as age, height, weight, and gender (see FIG. 2). The input result will be stored in the storage unit 2.

一劑量設定模組12,提供使用者設定劑量參數。劑量參數包括配方濃度與每次投藥量(請參閱圖二所示),設定結果將儲存於儲存單元2中。A dose setting module 12 provides a user setting dose parameter. The dose parameters include the formulation concentration and the amount of each dose (see Figure 2), and the results will be stored in the storage unit 2.

一自動新增投藥記錄設定模組13,提供使用者設定是否以自動模式進行新增投藥記錄,設定結果將儲存於儲存單元2中。An automatic new medication record setting module 13 is provided to provide a user to set whether to perform an additional medication record in the automatic mode, and the result of the setting is stored in the storage unit 2.

Ce 底限設定模組14,提供使用者設定作用部位濃度(Ce )之底限,設定結果將儲存於儲存單元2中。A Ce bottom setting module 14 provides a user to set a bottom limit of the concentration of the working portion ( Ce ), and the setting result is stored in the storage unit 2.

Ce 到達峰值警示設定模組15,提供使用者決定在Ce 達到局部峰值時是否經由音效與燈號警示單元6發出提示,設定結果將儲存於儲存單元2。A Ce reaches the peak alert setting module 15 to provide a user with a decision whether to issue a prompt via the sound effect and the light warning unit 6 when Ce reaches a local peak, and the setting result will be stored in the storage unit 2.

一處理單元3,依照應用藥物動力學之多腔室加作用部位的藥物動力學模型配合儲存單元2儲存之各輸入參數,以計算出作用部位濃度(例如腦部的藥劑濃度)的變化函數,並即時將計算所得的數據與圖形製作單元5輸出之圖形由顯示單元4中加以顯示,該顯示單元4可為任何一種顯示設備。a processing unit 3, according to the pharmacokinetic model of the multi-chamber plus action site using the pharmacokinetics, and the input parameters stored in the storage unit 2 to calculate a change function of the concentration of the active site (for example, the concentration of the drug in the brain), The calculated data and the graphic outputted by the graphic creating unit 5 are displayed by the display unit 4, and the display unit 4 can be any display device.

一計時單元31,其係接收處理單元3的計算結果後,即開始對Ce 鋒值到達時刻與Ce 底限到達時刻予以倒數計時,計時的過程供顯示單元4與圖形製作單元5顯示。A timing unit 31, which receives the calculation result of the processing unit 3, starts counting down the Ce front arrival time and the Ce bottom arrival time, and the timing is displayed for the display unit 4 and the graphic creation unit 5.

一顯示單元4,接收處理單元3的計算結果與計時單元31的倒數計時過程,即時顯示在顯示設備上。A display unit 4 receives the calculation result of the processing unit 3 and the countdown process of the timing unit 31, and displays it on the display device in real time.

一圖形製作單元5,接收處理單元3的計算結果後與計時單元31的倒數計時過程,繪製作用部位(Ce )函數的曲線,與時間記號(請參閱圖六所示),即時顯示在顯示設備上。a graphics making unit 5, after receiving the calculation result of the processing unit 3 and the counting process of the counting unit 31, plots the curve of the active part ( Ce ) function, and the time mark (refer to FIG. 6), and instantly displays it on the display device. on.

一音效與燈號警示單元6,當計時單元31倒數計時歸零時,處理單元3會驅使音效與燈號警示單元6發出警示聲響與燈號。An audio effect and signal warning unit 6, when the countdown unit 31 counts down to zero, the processing unit 3 drives the sound effect and the light warning unit 6 to sound an alarm sound and a light.

一投藥記錄編輯單元7,其係當音效與燈號警示單元6發出警示聲與燈號提示使用者投藥時,使用者應當手推投藥一次並手動新增一筆投藥記錄;萬一使用者輸入錯誤也能利用本單元刪除或修正投藥記錄。A medication record editing unit 7 is when the sound effect and the light warning unit 6 issues a warning sound and the light number prompts the user to administer the medicine, the user should push the medicine once and manually add a medication record; in case the user inputs the error This unit can also be used to delete or correct the medication record.

如圖四所示,茲以三腔室加作用部位藥物動力學模型圖為例,說明之:當投藥記錄更新後處理單元即會以此模型推算出作用部位濃度(Ce )的變化函數,以便進一步算出Ce 峰值、到達Ce 峰值時間及Ce 降至底限的時間,與即時的Ce 值,以下說明本發明推算的辦法:首先根據群體藥物動力學的研究結果可以由病患參數,例如性別、身高、體重、年齡等數據推算各腔室的體積與藥物交換速率常數、藥物代謝速率常數,當以手推注射投藥於靜脈時,藥劑會由中心部位(血漿)(V 1 )運送至快平衡部位(肌肉、腸胃系等)(V 2 )、慢平衡部位(脂肪等)(V 3 )、作用部位(例如腦部)(V e )、代謝排泄部位(肝臟、腎臟等),V 1 V 2 V 3 V e 表示各腔室之體積,而各腔室間的藥物交換速率常數分別為k12 ,k 21 ,k 13 ,k 31 ,藥物代謝速率常數為k 10 、作用部位的清除率常數為k eO 以及每次投藥後Ce 抵達峰值所需時間上限為t peak ;上述參數可以由群體藥物動力學的統計結果推算。As shown in Figure 4, the pharmacokinetic model of the three-chamber plus action site is taken as an example. When the dosage record is updated, the processing unit will calculate the change function of the concentration of the site ( Ce ). Further calculating the Ce peak, the Ce peak time, and the time when Ce falls to the bottom limit, and the instantaneous Ce value, the following describes the method of the present invention: first, according to the results of the group pharmacokinetic study, the patient parameters, such as gender, Height, weight, age and other data to calculate the volume and drug exchange rate constant of each chamber, drug metabolism rate constant, when the drug is injected into the vein by hand, the agent will be transported from the central part (plasma) ( V 1 ) to the fast balance Site (muscle, gastrointestinal system, etc.) ( V 2 ), slow-balanced site (fat, etc.) ( V 3 ), site of action (eg, brain) ( V e ), metabolic excretion site (liver, kidney, etc.), V 1 V 2 V 3 V e represents the volume of each chamber, and the drug exchange rate constants between the chambers are k 12 , k 21 , k 13 , k 31 , the drug metabolism rate constant is k 10 , and the clearance constant of the site of action For k eO and each time The upper limit of the time required for Ce to reach the peak is t peak ; the above parameters can be extrapolated from the statistical results of population pharmacokinetics.

λ 1 ,λ 2 ,λ 3 為下列多項式的三個解:Let λ 1 , λ 2 , λ 3 be the three solutions of the following polynomial:

x 3 +k 10 k 21 k 31 x 2 +(k 10 k 31 +k 21 k 31 +k 21 k 13 +k 10 k 21 +k 31 k 12 )x +(k 10 +k 12 +k 13 +k 21 +k 31 )=0 x 3 + k 10 k 21 k 31 x 2 +( k 10 k 31 + k 21 k 31 + k 21 k 13 + k 10 k 21 + k 31 k 12 ) x +( k 10 + k 12 + k 13 + k 21 + k 31 )=0

每經過一次手推藥劑後,Ce函數可表示為:After each push of the drug, the Ce function can be expressed as:

其中t 1 =推注時刻,Bolus 1 =推注劑量,Where t 1 = moment of bolus, Bolus 1 = bolus dose,

由於濃度函數具有加成性,所以經過n 次推注後,濃度函數加成為:Since the concentration function is additive, after n bolus injections, the concentration function is added as:

此處tt n Here tt n

因為Bolus i ,t i 皆屬已知(由投藥記錄而來),所以化簡為:Because Bolus i and t i are known (from the drug administration record), the simplification is:

其中δ1234 為常實數,Ce ’為Ce 的導函數。Where δ 1 , δ 2 , δ 3 , δ 4 are constant real numbers and Ce ' is a derivative of Ce .

接著用二分逼近法得出Ce 峰值(MaxCe )與Ce 峰值(t max )。因為Ce ’=0處Ce 有峰值,峰值之左Ce ’>0,峰值之右Ce ’<0,所以可以用二分逼近法得t max ,其演算法如下:Followed by dichotomy stars Ce peak (MaxCe) peak of Ce (t max) approximation. Since Ce '=0 at Ce has a peak, the left of the peak is Ce '>0, and the right of the peak is Ce '<0, so t max can be obtained by the binary approximation method. The algorithm is as follows:

接著用二分逼近法得出Ce 降至底限的時刻,在這裡的例子以24小時為上限,如果所需時間超過一天,演算法就傳回24小時後的時刻當作Ce 降至底限的時刻。其中,LBCe 是使用者自訂的Ce 底限,可視臨床需要而調整,由於t max 之後Ce 是遞減的所以用下列演算法可得到t LB Then use the binary approximation method to get the moment when Ce falls to the bottom limit. The example here is the upper limit of 24 hours. If the time required is more than one day, the algorithm returns the time after 24 hours as Ce falls to the bottom limit. time. Among them, LBCe is the user-defined Ce bottom limit, which can be adjusted according to clinical needs. Since Ce is decremented after t max , t LB can be obtained by the following algorithm:

請同時參閱圖五及圖六所示,為本發明一種應用藥物動力學模型的手推靜脈注射藥劑計算方法的執行流程圖:步驟一:系統接收選擇藥物與模型模組、病患基本資料設定模組、劑量設定模組、自動新增投藥記錄設定模組、Ce 底限設定模組、Ce 到達峰值警示設定模組之各項輸入與投藥記錄編輯單元之投藥記錄資料501。Please refer to FIG. 5 and FIG. 6 at the same time, which is a flow chart of the implementation method of the hand-injection intravenous medicament for applying the pharmacokinetic model of the present invention: Step 1: The system receives the selected drug and the model module, and sets the basic data of the patient. The module, the dose setting module, the automatic new drug registration setting module, the Ce floor setting module, the Ce input peak warning setting module, and the medication record data 501 of the medication record editing unit.

步驟二:儲存單元儲存各項設定參數502。Step 2: The storage unit stores various setting parameters 502.

步驟三:處理單元計算出Ce 函數及其導函數的各項係數與Ce 峰值(MaxCe )、Ce 到達峰值時間(t max )、Ce 降至底限時間(t LB )503。Step 3: The processing unit calculates coefficients of the Ce function and its derivative function, Ce peak ( MaxCe ), Ce peak time ( t max ), and Ce drop time ( t LB ) 503.

步驟四:依據步驟三計算後之Ce(t)、投藥總量、MaxCet max t LB 等數據顯示於顯示單元或經圖形製作單元後顯示於顯示單元504。Step Four: According Ce (t) is calculated after the three steps, the total amount of drug administered, MaxCe, t max, t LB and other data on the display unit 504 or the display unit by the pattern creating means.

步驟五:顯示單元及圖形製作單元依據步驟四之數據t max t LB 以及配合步驟一之Ce 到達峰值警示設定模組,當到達t max t LB 會以不同的警示聲與燈號通知使用者505。Step 5: The display unit and the graphic creation unit arrive at the peak warning setting module according to the data t max and t LB in step 4 and the Ce in step 1. When the arrival of t max and t LB is notified by different warning sounds and lights 505.

步驟六:若自動新增投藥記錄設定模組設定為開啟,而且Ce 降至底限(now >t LB ),則自動新增一筆投藥記錄。此模式下,使用者聽聞警告聲響或看見燈號便隨之投藥,無需再輸入投藥記錄506;若自動新增投藥記錄設定為不新增,則進行步驟七。Step 6: If the automatic new medication record setting module is set to on and Ce falls to the bottom limit ( now > t LB ), a new medication record is automatically added. In this mode, the user will hear the warning sound or see the light signal, and then do not need to input the medication record 506; if the automatic new medication record is set to not add, proceed to step 7.

步驟七:若使用者按下結束鍵則結束程式507,若未按下結束鍵則重覆步驟一步驟六,不斷計算及顯示即時數據與圖形,直到使用者按下結束鍵為止。Step 7: If the user presses the end key, the program 507 is ended. If the end key is not pressed, the step 1 is repeated, and the instant data and graphics are continuously calculated and displayed until the user presses the end key.

請參考圖六所示,為本發明一種應用藥物動力學模型的手推靜脈注射藥劑計算系統及方法的圖形製作單元所輸出圖形的示意圖。Please refer to FIG. 6 , which is a schematic diagram of the output pattern of the graphic production unit of the hand-push intravenous drug calculation system and method using the pharmacokinetic model of the present invention.

其中,x軸為時間(sec),y軸為作用部位濃度(mcg/ml),並有一使用者設定之作用部位濃度底限(LBCe )。開始注射藥劑後,Ce 首先遞增,經過一段時間後Ce 會抵達峰值(Ce 峰值1),抵達Ce 峰值1之時間為t max 1,然後Ce 會遞減,下降至LBCe 之時間為t LB 1;使用者聽聞音效與燈號警示,若再度投藥,同時新增投藥記錄;接著Ce 又會上升到新的峰值(Ce 峰值2),抵達的時間為t max 2,其後Ce 下降至LBCe 之時間為t LB 2,如此反覆進行到使用者停止使用為止;圖形製作單元將不斷即時更新圖形,直到執行結束。The x-axis is time (sec), the y-axis is the concentration of the active site (mcg/ml), and there is a user-defined concentration limit ( LBCe ). After the start of the injection of the drug, Ce first increases, after a period of time, Ce will reach the peak ( Ce peak 1), the time to reach Ce peak 1 is t max 1, then Ce will decrease, and the time to fall to LBCe is t LB 1; The person hears the sound effect and the signal warning, if the drug is re-dosed, and the drug record is added; then Ce will rise to the new peak ( Ce peak 2), the arrival time is t max 2, and then the time when Ce falls to LBCe is t LB 2, so repeated until the user stops using it; the graphics production unit will continuously update the graphics in real time until the execution ends.

本系統可儲存於電腦可讀取記錄媒體,當電腦載入本程式並執行後,即可完成本發明。The system can be stored in a computer readable recording medium, and the present invention can be completed when the computer is loaded into the program and executed.

本系統也可整合於病床邊之監視器、麻醉機、行動裝置、計算機、或麻醉記錄軟體之內,當上述儀器載入本程式並執行後,即可完成本發明。The system can also be integrated into a bedside monitor, an anesthesia machine, a mobile device, a computer, or an anesthesia recording software. Once the instrument is loaded into the program and executed, the present invention can be completed.

本發明與其他習用技術相互比較時,更具備下列優點:The invention has the following advantages when compared with other conventional technologies:

1.應用藥物動力學之多腔室加作用部位藥動模型,依據群體藥物動力學推論各藥物動力學參數,然後以投藥記錄推算已投藥量、即時作用部位濃度(Ce )值、Ce 峰值與Ce 到達峰值的時間、Ce 降至底限所需時間,並隨時顯示給使用者參考。1. Apply pharmacokinetic multi-chamber plus action site pharmacokinetic model, infer the pharmacokinetic parameters according to group pharmacokinetics, and then calculate the drug dosage, the concentration of immediate action site ( Ce ), Ce peak and The time when Ce reaches the peak and the time required for Ce to fall to the bottom limit are displayed to the user at any time.

2.提供音效與燈號警示單元,當作用部位濃度降至Ce 底限會以鈴聲與燈號警示之方式提醒使用者追加藥劑。2. Provide the sound effect and signal warning unit. When the concentration of the active part falls to the Ce limit, the user will be reminded to add the medicine by means of ringing and signal warning.

3.提供到達Ce 峰值警示,提示何時達到預期藥效可以進行投藥的目的(例如開始手術)。3. Provide a Ce peak warning to indicate when the expected efficacy is achieved for the purpose of administering the drug (eg, starting surgery).

上列詳細說明係針對本發明之一可行實施例之具體說明,惟該實施例並非用以限制本發明之專利範圍,凡未脫離本發明技藝精神所為之等效實施或變更,均應包含於本案之專利範圍中。The detailed description of the preferred embodiments of the present invention is intended to be limited to the scope of the invention, and is not intended to limit the scope of the invention. The patent scope of this case.

綜上所述,本案不但在技術思想上確屬創新,並能較習用物品增進上述多項功效,應已充分符合新穎性及進步性之法定發明專利要件,爰依法提出申請,懇請 貴局核准本件發明專利申請案,以勵發明,至感德便。To sum up, this case is not only innovative in terms of technical thinking, but also able to enhance the above-mentioned multiple functions compared with conventional articles. It should fully comply with the statutory invention patent requirements of novelty and progressiveness, and apply in accordance with the law. I urge you to approve this article. Invention patent application, in order to invent invention, to the sense of virtue.

10...選擇藥物與模型模組10. . . Select drug and model module

11...病患基本資料設定模組11. . . Patient basic data setting module

12...劑量設定模組12. . . Dose setting module

13...自動新增投藥記錄設定模組13. . . Automatically add medication record setting module

14...Ce 底限設定模組14. . . Ce floor setting module

15...Ce 到達峰值警示設定模組15. . . Ce reaches the peak warning setting module

2...儲存單元2. . . Storage unit

3...處理單元3. . . Processing unit

31...計時單元31. . . Timing unit

4...顯示單元4. . . Display unit

5...圖形製作單元5. . . Graphic production unit

6...音效與燈號警示單元6. . . Sound effect and light warning unit

7...投藥記錄編輯單元7. . . Drug record editing unit

圖一為本發明一種應用藥物動力學模型的手推靜脈注射藥劑計算系統及方法之架構圖;1 is an architectural diagram of a system and method for calculating a hand-injected intravenous medicament using a pharmacokinetic model;

圖二為本發明一種應用藥物動力學模型的手推靜脈注射藥劑計算系統及方法之使用者介面輸入模組示意圖;2 is a schematic diagram of a user interface input module of a hand-push intravenous drug calculation system and method using a pharmacokinetic model according to the present invention;

圖三為本發明一種應用藥物動力學模型的手推靜脈注射藥劑計算系統及方法之使用者介面顯示單元示意圖;3 is a schematic diagram of a user interface display unit of a hand-push intravenous drug calculation system and method using a pharmacokinetic model according to the present invention;

圖四為本發明一種應用藥物動力學模型的手推靜脈注射藥劑計算系統及方法之藥物動力學之三腔室加作用部位藥動模型;Figure 4 is a pharmacokinetic three-chamber plus action site pharmacokinetic model of a hand-push intravenous drug calculation system and method using a pharmacokinetic model;

圖五本發明一種應用藥物動力學模型的手推靜脈注射藥劑計算系統及方法之圖形製作單元之圖形示意圖;以及Figure 5 is a schematic diagram of a graphic production unit of a hand-push intravenous drug calculation system and method using a pharmacokinetic model;

圖六為本發明一種應用藥物動力學模型的手推靜脈注射藥劑計算系統及方法之系統步驟流程圖Figure 6 is a flow chart showing the system steps of a system and method for calculating a hand-injected intravenous drug using a pharmacokinetic model according to the present invention.

10...選擇藥物與藥物動力學模型模組10. . . Drug and pharmacokinetic model module

11...病患基本資料設定模組11. . . Patient basic data setting module

12...劑量設定模組12. . . Dose setting module

13...自動新增投藥記錄設定模組13. . . Automatically add medication record setting module

14...Ce底限設定模組14. . . Ce floor setting module

15...Ce到達峰值警示設定模組15. . . Ce reaches the peak warning setting module

2...儲存單元2. . . Storage unit

3...處理單元3. . . Processing unit

31...計時單元31. . . Timing unit

4...顯示單元4. . . Display unit

5...圖形製作單元5. . . Graphic production unit

6...音效與燈號警示單元6. . . Sound effect and light warning unit

7...投藥記錄編輯單元7. . . Drug record editing unit

Claims (11)

一種應用藥物動力學模型的手推靜脈注射藥劑計算系統,係包含:一選擇藥物與模型模組,其係提供多種藥物及藥物動力學模型供使用者選擇;一病患基本資料設定模組,其係提供使用者輸入病患基本資料參數;一劑量設定模組,其係提供使用者設定每次投藥劑量與配方濃度;一自動新增投藥記錄設定模組,其係提供選擇是否開啟自動新增投藥記錄模式;一作用部位濃度底限設定模組,其係供調整作用部位濃度底限的功能;一作用部位濃度到達峰值警示設定模組,其係供選擇是否開啟音效與燈號警示單元;一儲存單元,其係儲存上述參數設定,以供處理單元進行運算;一處理單元,其係應用藥物動力學之三腔室加作用部位藥動模型,配合儲存單元之參數設定與投藥記錄計算出作用部位濃度函數與即時數據,並隨時將數據顯示於顯示單元,並隨時依據投藥記錄編輯單元,將投藥量與投藥時間顯示於顯示單元;一顯示單元,其係顯示處理單元計算出之即時數據與圖形製作單元繪出之圖形;一計時單元,其係以倒數計時的方式,顯示到達作用部位濃度峰值所需時間與作用部位濃度降至底限所需時間,並於到達時發出音效與燈號警示;一音效與燈號警示單元,其係配合計時單元當作用部位濃度到達底限時,通知使用者手動推注藥劑,當作用部位濃度到達峰值,通知手術可開始;一投藥記錄編輯單元,其係用以新增刪除或修正投藥記錄。A hand-push intravenous drug calculation system using a pharmacokinetic model includes: a selection drug and a model module, which provides a plurality of drug and pharmacokinetic models for the user to select; a patient basic data setting module, It provides the user with input of the patient's basic data parameters; a dose setting module, which provides the user to set the dose and formula concentration for each dose; an automatic new medication record setting module, which provides a choice whether to open the automatic new Adding drug recording mode; a concentration limit setting module for the action part, which is a function for adjusting the concentration limit of the action part; a concentration of the action part reaches the peak warning setting module, which is for selecting whether to turn on the sound effect and the light warning unit a storage unit for storing the above parameter settings for processing by the processing unit; a processing unit for applying a pharmacokinetic three-chamber plus action site drug model, in conjunction with parameter setting of the storage unit and calculation of the drug administration record The concentration function and real-time data of the action site are displayed, and the data is displayed on the display unit at any time, and can be The medication record editing unit displays the dosage and the administration time on the display unit; a display unit displays the real-time data calculated by the processing unit and the graphic drawn by the graphic creation unit; and a timing unit, which is counted in a countdown manner , showing the time required to reach the peak concentration of the action site and the time required for the concentration of the action site to fall to the bottom limit, and sound effect and light warning upon arrival; a sound effect and light warning unit, which is matched with the timing unit as the concentration of the action site When the limit is reached, the user is notified to manually inject the medicament, and when the concentration of the active site reaches a peak, the notification operation can be started; and a medication record editing unit is used to newly delete or correct the medication record. 如申請專利範圍第1項所述之一種應用藥物動力學模型的手推靜脈注射藥劑計算系統,其中該病患基本資料設定模組之參數包含:年齡、身高、體重及性別或其他群體藥物動力學可能使用之參數。A hand-injection intravenous drug calculation system using a pharmacokinetic model according to claim 1, wherein the parameter of the patient basic data setting module comprises: age, height, weight and gender or other group drug dynamics Learn the parameters that may be used. 如申請專利範圍第1項所述之一種應用藥物動力學模型的手推靜脈注射藥劑計算系統,其中劑量設定模組之劑量設定參數更包含投藥配方濃度及每次投藥量。A hand-injection drug calculation system using a pharmacokinetic model according to claim 1, wherein the dose setting parameter of the dose setting module further comprises a concentration of the administration formula and a dose per administration. 如申請專利範圍第1項所述之一種應用藥物動力學模型的手推靜脈注射藥劑計算系統,其中該自動新增投藥記錄設定模組之自動記錄設定可依需求,於密集投藥的場景,選擇開啟,使用者聽到警示聲後立即推注藥劑,系統於此模式下,則會依照設定之每次投藥量於投藥記錄中自動新增投藥記錄。The hand-push intravenous drug calculation system using the pharmacokinetic model described in claim 1, wherein the automatic record setting module of the automatic new drug-receiving record setting module can be selected according to requirements in an intensive drug-administration scenario. When the user hears the warning sound, the medicine is injected immediately. In this mode, the dosage record is automatically added to the medication record according to the set dosage. 如申請專利範圍第1項所述之一種應用藥物動力學模型的手推靜脈注射藥劑計算系統,其中該投藥記錄編輯單元包含新增、刪除及修正投藥記錄的功能。A hand-injection intravenous drug calculation system using a pharmacokinetic model according to claim 1, wherein the administration record editing unit includes a function of adding, deleting, and correcting a drug administration record. 如申請專利範圍第1項所述之一種應用藥物動力學模型的手推靜脈注射藥劑計算系統,其中該音效與燈號警示單元,當即將到達作用部位濃度底限會以警示聲與燈號提示,使用者無需時時注視顯示單元而能輕鬆掌握作用部位濃度的變化。A hand-injection intravenous drug calculation system using a pharmacokinetic model according to claim 1, wherein the sound effect and the light warning unit are prompted by the warning sound and the light when the concentration limit of the action site is reached. The user can easily grasp the change of the concentration of the action part without looking at the display unit from time to time. 如申請專利範圍第1項所述之一種應用藥物動力學模型的手推靜脈注射藥劑計算系統,其中該處理單元計算之即時數據包含目前作用部位濃度、投藥總劑量、作用部位濃度峰值、作用部位濃度底限及其到達時間等數據,並隨著使用者修改投藥記錄而重新計算上列數據。A hand-injection intravenous drug calculation system using a pharmacokinetic model according to claim 1, wherein the current data calculated by the processing unit includes a current concentration of the active site, a total dose of the drug, a peak concentration of the site of action, and a site of action. Data such as concentration threshold and arrival time, and recalculate the above data as the user modifies the medication record. 如申請專利範圍第1項所述之一種應用藥物動力學模型的手推靜脈注射藥劑計算系統,其中該顯示單元顯示之即時數據包含目前作用部位濃度、投藥總劑量、作用部位濃度峰值與到達峰值時間,以及作用部位濃度降至底限時間等數據,並即時依據投藥記錄的更新而重新計算並顯示之。A hand-injection intravenous drug calculation system using a pharmacokinetic model according to claim 1, wherein the display unit displays the current data including the current site concentration, the total dose, the peak concentration and the peak of the site. The time, as well as the concentration of the site of action to the baseline time, are immediately recalculated and displayed based on the update of the dosing record. 如申請專利範圍第1項所述之一種應用藥物動力學模型的手推靜脈注射藥劑計算系統,其中該顯示單元可將資料顯示於監視器、螢幕、電腦、手機或計算機等行動裝置上。A hand-injection intravenous drug calculation system using a pharmacokinetic model according to claim 1, wherein the display unit can display the data on a mobile device such as a monitor, a screen, a computer, a mobile phone or a computer. 一種應用藥物動力學模型的手推靜脈注射藥劑計算方法,包含:步驟一:系統接收藥物與藥物動力學模型選擇、病患基本資料設定模組、劑量設定模組、自動新增投藥記錄設定模組、作用部位濃度底限設定模組或作用部位濃度到達峰值警示設定模組之各項輸入與投藥記錄編輯單元之投藥記錄;步驟二:儲存單元儲存各項設定參數;步驟三:處理單元計算出作用部位濃度函數之係數與Ce 峰值(MaxCe )、Ce 到達峰值時間(t max )及Ce 降至底限時間(t LB );步驟四:依據步驟三計算後之即時作用部位濃度、投藥總量、作用部位濃度峰值、到達作用部位濃度峰值的時間及作用部位濃度降至底限的時間,等等數據顯示於顯示單元或經圖形製作單元後顯示於顯示單元;步驟五:顯示單元及圖形製作單元依據步驟四之數據以及配合步驟一之作用部位濃度到達峰值警示設定模組,當到達作用部位濃度峰值或作用部位濃度降至底限的時間會以不同的警示聲與燈號通知使用者;步驟六:判斷若自動新增投藥記錄設定為開啟,而且作用部位濃度已經降至底限,則自動新增一筆投藥記錄;若為關閉,則進行步驟七;步驟七:若使用者按下結束鍵則結束程式,若未按下結束鍵則重覆步驟一步驟六,不斷計算及顯示即時數據與圖形,直到使用者按下結束鍵為止。A method for calculating a hand-injected intravenous medicament using a pharmacokinetic model comprises: step 1: receiving a drug and pharmacokinetic model selection, a patient basic data setting module, a dose setting module, and an automatic new medication recording setting mode The group, the concentration limit setting module of the action part or the concentration of the action part reaches the input record of the peak warning setting module and the administration record of the administration record editing unit; Step 2: the storage unit stores each setting parameter; Step 3: Processing unit calculation coefficient function of the site of action of Ce concentration peak (MaxCe), Ce to peak time (t max) and Ce reduced floor time (t LB); step IV: after the immediate site of action is calculated according to the concentration step three, the total administration The amount, the peak concentration of the action site, the time to reach the peak concentration of the action site, and the time when the concentration of the action site falls to the bottom limit, and the like are displayed on the display unit or displayed on the display unit after being formed by the graphic unit; Step 5: Display unit and graphic The production unit according to the data of step 4 and the concentration of the action part of the step 1 reaches the peak warning setting The module will notify the user with different warning sounds and lights when the peak of the concentration of the active part or the concentration of the active part falls to the bottom limit; Step 6: Determine if the automatic new medication record is set to ON and the concentration of the active site If it has dropped to the bottom limit, it will automatically add a new medication record; if it is off, proceed to step 7; Step 7: If the user presses the end button, the program ends. If the end button is not pressed, repeat step one six. Continuously calculate and display real-time data and graphics until the user presses the end key. 一種內儲程式之電腦可讀取記錄媒體,當電腦載入該程式並執行後,即可完成申請專利範圍第10項之方法。 A computer capable of reading a program can read the recording medium, and when the computer loads the program and executes it, the method of claim 10 can be completed.
TW98133924A 2009-10-07 2009-10-07 Method and method of hand - push intravenous injection of pharmacokinetic model TWI381862B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
TW98133924A TWI381862B (en) 2009-10-07 2009-10-07 Method and method of hand - push intravenous injection of pharmacokinetic model

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW98133924A TWI381862B (en) 2009-10-07 2009-10-07 Method and method of hand - push intravenous injection of pharmacokinetic model

Publications (2)

Publication Number Publication Date
TW201113061A TW201113061A (en) 2011-04-16
TWI381862B true TWI381862B (en) 2013-01-11

Family

ID=44909476

Family Applications (1)

Application Number Title Priority Date Filing Date
TW98133924A TWI381862B (en) 2009-10-07 2009-10-07 Method and method of hand - push intravenous injection of pharmacokinetic model

Country Status (1)

Country Link
TW (1) TWI381862B (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW290442B (en) * 1994-11-04 1996-11-11 Elan Med Tech

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW290442B (en) * 1994-11-04 1996-11-11 Elan Med Tech

Also Published As

Publication number Publication date
TW201113061A (en) 2011-04-16

Similar Documents

Publication Publication Date Title
Moerman et al. Manual versus target-controlled infusion remifentanil administration in spontaneously breathing patients
JP2019083071A5 (en)
US20080097167A1 (en) System and method for displaying a pharmacokinetic and pharmacodynamic drug model
FR2876590A1 (en) ANESTHESIA APPARATUS
JP2020507431A (en) Drug injection device
JP2019523659A (en) Method and control device for controlling administration of propofol to a patient
CN110176286A (en) Analysis about patient care
KR102328988B1 (en) Patient care device-specific configuration output
KR20180007414A (en) Method for infusing drug to patients using infusion pump, and terminal for patient using the same
TWI381862B (en) Method and method of hand - push intravenous injection of pharmacokinetic model
Walsh et al. A comparison of two different ketamine and diazepam combinations with an alphaxalone and medetomidine combination for induction of anaesthesia in sheep
US10369276B2 (en) Accurately delivering partial doses of a drug post dilution using an injector
Liou et al. A response surface model exploration of dosing strategies in gastrointestinal endoscopies using midazolam and opioids
JP2017086098A (en) Liquid sending pump
Tsals Usability evaluation of intradermal adapters (IDA)
Naidoo Target controlled infusions
WO2020199115A1 (en) Monitoring method, monitor and central station
Dang et al. Analysis of symposium articles on insulin pen devices and alternative insulin delivery methods
US20040133186A1 (en) Programmed pulsed infusion methods and devices
WO2014049658A1 (en) Fluid delivery device, fluid delivery system, and control method for fluid delivery device
JP2005013542A (en) Nursing support apparatus
US20220301681A1 (en) System and Method for Infusion of Drugs
MILLER-BELL et al. PHARMACOLOGY IN NEONATAL CARE
JP2010540134A (en) Transportation apparatus and method for supplying a chemical mixture
JP2007275609A (en) Syringe

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees